Copeland Capital Management’s Phibro Animal Health PAHC Stock Holding History

Copeland Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-602	Closed	-$10K	–	283
2020 Q3	$10K	Hold	602	–	–	﹤0.01%	198
2020 Q2	$16K	Buy	602 +19	+3%	+$472	﹤0.01%	179
2020 Q1	$14K	Buy	583 +58	+11%	+$1.42K	﹤0.01%	185
2019 Q4	$13K	Hold	525	–	–	﹤0.01%	212
2019 Q3	$11K	Buy	525 +8	+2%	+$219	﹤0.01%	213
2019 Q2	$16K	Buy	517 +23	+5%	+$721	﹤0.01%	184
2019 Q1	$16K	Buy	494 +17	+4%	+$529	﹤0.01%	174
2018 Q4	$15K	Buy	+477	New	+$18K	﹤0.01%	167

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Copeland Capital Management's PAHC Position: Q4 2020 in Review

Copeland Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2020, closing a stake of 602 shares — an estimated $10K sold.

Copeland Capital Management first reported a position in PAHC in Q4 2018 and held it in 8 quarters. The position peaked at $16K in Q2 2020. 136 funds tracked by Wall St. Rank hold PAHC as of Q4 2020.

Copeland Capital Management reported no remaining Phibro Animal Health position as of Q4 2020 after selling out during the quarter.
Copeland Capital Management sold 602 Phibro Animal Health shares in Q4 2020, an estimated $10K.
Copeland Capital Management first reported a position in Phibro Animal Health in Q4 2018 and held it in 8 quarters.
Copeland Capital Management's Phibro Animal Health position peaked at $16K in Q2 2020.
136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2020.

Based on Copeland Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.